QLS12010
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 16, 2026
A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=160 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1